Minimal Invasive Transcatheter Mitral Valve Interventions
Özet
This chapter focuses on minimal invasive transcatheter mitral valve interventions using devices like the NeoChord DS1000 system. This approach enables mitral valve repair without cardiopulmonary bypass, reducing recovery time and complication risks. The NeoChord system allows for artificial chordae implantation and is commonly used to treat degenerative mitral valve disease.
Bu bölüm, NeoChord DS1000 gibi sistemler kullanılarak gerçekleştirilen minimal invaziv transkateter mitral kapak girişimlerini ele almaktadır. Bu yöntem, kardiyopulmoner baypas olmadan mitral kapak tamirini mümkün kılarak iyileşme süresini kısaltır ve komplikasyon riskini azaltır. NeoChord sistemi, yapay kordların yerleştirilmesine olanak sağlar ve degeneratif mitral kapak hastalıklarının tedavisinde tercih edilir.
Referanslar
Enriquez-Sarano M, Nkomo VT, Michelena HI. Mitral Regurgitation. In: Wang A, Bashore TM, editors. Valvular Heart Disease. Totowa, NJ: Humana Press; 2009. p. 221-46.
Bach DS, Awais M, Gurm HS, Kohnstamm S. Failure of guideline adherence for intervention in patients with severe mitral regurgitation. Journal of the American College of Cardiology. 2009;54(9):860-5.
Mahmood F, Karthik S, Subramaniam B, Panzica PJ, Mitchell J, Lerner AB, et al. Intraoperative application of geometric three-dimensional mitral valve assessment package: a feasibility study. Journal of cardiothoracic and vascular anesthesia. 2008;22(2):292-8.
Mirabel M, Iung B, Baron G, Messika-Zeitoun D, Détaint D, Vanoverschelde J-L, et al. What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery? European heart journal. 2007;28(11):1358-65.
Braunberger E, Deloche A, Berrebi A, Fayssoil A, Celestin J, Meimoun P, et al. Very long-term results (more than 20 years) of valve repair with Carpentier’s techniques in nonrheumatic mitral valve insufficiency. Circulation. 2001;104(suppl_1):I-8-I-11.
David TE, Ivanov J, Armstrong S, Christie D, Rakowski H. A comparison of outcomes of mitral valve repair for degenerative disease with posterior, anterior, and bileaflet prolapse. The Journal of thoracic and cardiovascular surgery. 2005;130(5):1242-9.
Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin III JP, Gentile F, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Journal of the American College of Cardiology. 2021;77(4):450-500.
Vahanian A, Beyersdorf F, Praz F, Milojevic M, Baldus S, Bauersachs J, et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease: developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). European heart journal. 2022;43(7):561-632.
Perier P, Hohenberger W, Lakew F, Batz G, Urbanski P, Zacher M, et al. Toward a new paradigm for the reconstruction of posterior leaflet prolapse: midterm results of the “respect rather than resect” approach. The Annals of thoracic surgery. 2008;86(3):718-25.
Colli A, Manzan E, Aidietis A, Rucinskas K, Bizzotto E, Besola L, et al. An early European experience with transapical off-pump mitral valve repair with NeoChord implantation. European Journal of Cardio-Thoracic Surgery. 2018;54(3):460-6.
Colli A, Manzan E, Besola L, Bizzotto E, Fiocco A, Zucchetta F, et al. One-year outcomes after transapical echocardiography-guided mitral valve repair. Circulation. 2018;138(8):843-5.
Colli A, Manzan E, Zucchetta F, Bizzotto E, Besola L, Bagozzi L, et al. Transapical off-pump mitral valve repair with Neochord implantation: early clinical results. International journal of cardiology. 2016;204:23-8.
McGoon DC. Repair of mitral insufficiency due to ruptured chordae tendineae. The Journal of Thoracic and Cardiovascular Surgery. 1960;39(3):357-62.
Seeburger J, Borger MA, Tschernich H, Leontjev S, Holzhey D, Noack T, et al. Transapical beating heart mitral valve repair. Circulation: Cardiovascular Interventions. 2010;3(6):611-2.
Colli A, Besola L, Bizzotto E, Fiocco A, Denas G, Bellu R, et al. Mechanisms of recurrent regurgitation after transapical off-pump mitral valve repair with neochord implantation. European Journal of Cardio-Thoracic Surgery. 2019;56(3):479-87.
Colli A, Manzan E, Rucinskas K, Janusauskas V, Zucchetta F, Zakarkaitė D, et al. Acute safety and efficacy of the NeoChord procedure. Interactive cardiovascular and thoracic surgery. 2015;20(5):575-81.
Seeburger J, Rinaldi M, Nielsen SL, Salizzoni S, Lange R, Schoenburg M, et al. Off-pump transapical implantation of artificial neo-chordae to correct mitral regurgitation: the TACT Trial (Transapical Artificial Chordae Tendinae) proof of concept. Journal of the American College of Cardiology. 2014;63(9):914-9.
Manzan E, Azzolina D, Gregori D, Bizzotto E, Colli A, Gerosa G. Combining echocardiographic and anatomic variables to predict outcomes of mitral valve repair with the NeoChord procedure. Annals of cardiothoracic surgery. 2021;10(1):122.
D’Onofrio A, Mastro F, Nadali M, Fiocco A, Pittarello D, Aruta P, et al. Transapical beating heart mitral valve repair versus conventional surgery: a propensity-matched study. Interactive CardioVascular and Thoracic Surgery. 2022;35(1):ivac053.
Colli A, Besola L, Montagner M, Azzolina D, Soriani N, Manzan E, et al. Prognostic impact of leaflet-to-annulus index in patients treated with transapical off-pump echo-guided mitral valve repair with NeoChord implantation. International journal of cardiology. 2018;257:235-7.
Colli A, Besola L, Montagner M, Soriani N, Manzan E, Bizzotto E, et al. Acute intraoperative echocardiographic changes after transapical off-pump mitral valve repair with NeoChord implantation. International journal of cardiology. 2018;257:230-4.
Colli A, Adams D, Fiocco A, Pradegan N, Longinotti L, Nadali M, et al. Transapical NeoChord mitral valve repair. Annals of cardiothoracic surgery. 2018;7(6):812.
Colli A, Bagozzi L, Banchelli F, Besola L, Bizzotto E, Pradegan N, et al. Learning curve analysis of transapical NeoChord mitral valve repair. European Journal of Cardio-Thoracic Surgery. 2018;54(2):273-80.
Colli A, Manzan E, Zucchetta F, Sarais C, Pittarello D, Gerosa G. Feasibility of anterior mitral leaflet flail repair with transapical beating-heart neochord implantation. JACC: Cardiovascular Interventions. 2014;7(11):1320-1.
Bajona P, Katz WE, Daly RC, Zehr KJ, Speziali G. Beating-heart, off-pump mitral valve repair by implantation of artificial chordae tendineae: an acute in vivo animal study. The Journal of thoracic and cardiovascular surgery. 2009;137(1):188-93.
J. G. Harpoon Transapical: Technology and Clinical Updates2019.
Lancellotti P, Radermecker M, Durieux R, Modine T, Oury C, Fattouch K. Transapical beating-heart chordae implantation in mitral regurgitation: a new horizon for repairing mitral valve prolapse. Journal of thoracic disease. 2016;8(12):E1665.
Rucinskas K, Janusauskas V, Zakarkaite D, Aidietiene S, Samalavicius R, Speziali G, et al. Off-pump transapical implantation of artificial chordae to correct mitral regurgitation: early results of a single-center experience. The Journal of thoracic and cardiovascular surgery. 2014;147(1):95-9.
Gerosa G, Nadali M, Longinotti L, Ponzoni M, Caraffa R, Fiocco A, et al. Transapical off-pump echo-guided mitral valve repair with neochordae implantation mid-term outcomes. Annals of Cardiothoracic Surgery. 2021;10(1):131.
Gammie JS, Wilson P, Bartus K, Gackowski A, Hung J, D’Ambra MN, et al. Transapical beating-heart mitral valve repair with an expanded polytetrafluoroethylene cordal implantation device: initial clinical experience. Circulation. 2016;134(3):189-97.
Salihi S, Özalp B, Saçlı H, Kara İ, Köksal C. Is trans-apical off-pump neochord implantation a safe and effective procedure for mitral valve repair? Anatolian Journal of Cardiology. 2019;22(6):319.
Kiefer P, Meier S, Noack T, Borger MA, Ender J, Hoyer A, et al. Good 5-year durability of transapical beating heart off-pump mitral valve repair with neochordae. The Annals of thoracic surgery. 2018;106(2):440-5.
Coutinho GF. Transapical off-pump mitral valve repair with NeoChord implantation: Is less better? Revista portuguesa de cardiologia. 2021;40(12):943-5.
Gammie JS, Bartus K, Gackowski A, D’Ambra MN, Szymanski P, Bilewska A, et al. Beating-heart mitral valve repair using a novel ePTFE cordal implantation device: a prospective trial. Journal of the American College of Cardiology. 2018;71(1):25-36.
Gammie JS, Bartus K, Gackowski A, Szymanski P, Bilewska A, Kusmierczyk M, et al. Safety and performance of a novel transventricular beating heart mitral valve repair system: 1-year outcomes. European Journal of Cardio-Thoracic Surgery. 2021;59(1):199-206.
Nkomo VT, Gardin JM, Skelton TN, et al. Burden of valvular heart diseases: a population-based study. Lancet 2006;368:1005-11
Goel SS, Bajaj N, Aggarwal B, et al. Prevalence and outcomes of unoperated patients with severe symptomatic mitral regurgitation and heart failure: comprehensive analysis to determine the potential role of MitraClip for this unmet need. J Am Coll Cardiol 2014;63:185-6.
Fiorilli PN, Herrmann HC. Transcatheter mitral valve replacement: Rationale and current status. Annu Rev Med [Internet]. 2020;71(1):249–61
Nishimura RA, Otto CM,Bonow RO, et al. 2017. 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College ofCardiology/American Heart Association Task Force on Clinical Practice Guidelines. J. Am. Coll. Cardiol.70:252–89
Vahanian A, Alfieri O, Andreotti F, et al. 2012. Guidelines on the management of valvular heart disease(version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the EuropeanSociety of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur.J. Cardiothorac. Surg. 42:S1–44
Castillo JG, Anyanwu AC, Fuster V, AdamsDH. 2012.A near 100% repair rate formitral valve prolapse is achievable in a reference center: implications for future guidelines. J. Thorac. Cardiovasc. Surg. 144:308–12
Mehta RH, Eagle KA, Coombs LP, et al. 2002. Influence of age on outcomes in patients undergoing mitral valve replacement. Ann. Thorac. Surg. 74:1459–67
Trichon BH, Felker GM, Shaw LK, et al. 2003. Relation of frequency and severity of mitral regurgitation to survival among patients with left ventricular systolic dysfunction and heart failure. Am. J. Cardiol. 91:538–43
Mirabel M, Iung B, Baron G, et al. What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery? Eur Heart J 2007;28:1358-65
Leon MB, Smith CR, Mack MJ, et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med 2016;374:1609-20, Mack MJ, Leon MB, Thourani VH, et al. Transcatheter aortic-valve replacement with a balloon-expandable valve
Rosendal C, Hien MD, Bruckner T, et al. 2012. Left ventricular outflow tract:intraoperative measurement and changes caused by mitral valve surgery. J. Am. Soc. Echocardiogr. 25:166–72
Guerrero M, Dvir D, Himbert D, et al. 2016. Transcatheter mitral valve replacement in native mitral valve disease with severe mitral annular calcification: results from the first multicenter global registry. JACC Cardiovasc. Interv. 9:1361–71 and Paradis JM, Del Trigo M, Puri R, Rodés-Cabau J. 2015. Transcatheter valve-in-valve and valve-in-ring for treating aortic and mitral surgical prosthetic dysfunction. J. Am. Coll. Cardiol. 66:2019–37
Muller DWM, Farivar RS, Jansz P, et al. 2017. Transcatheter mitral valve replacement system symptomatic mitral regurgitation: a global feasibility trial. J. Am. Coll. Cardiol. 69:381–91, Sorajja P, Moat N, Badhwar V, et al. 2019. Initial feasibility study of a new transcatheter mitral prosthesis: the first 100 patients. J. Am. Coll. Cardiol. 73:1250–60
Lutter G, Lozonschi L, Ebner A, et al. First-in-human off-pump transcatheter mitral valve replacement. JACC Cardiovasc Interv 2014;7:1077-8
Beller JP, Rogers JH, Thourani VH, Ailawadi G. Early clinical results with the Tendyne transcatheter mitral valve replacement system. Ann Cardiothorac Surg. 2018 Nov;7(6):776-779.
Quarto C, Davies S, Duncan A, et al. Transcatheter Mitral Valve Implantation: 30-day Outcome of First-in-Man Experience With an Apically Tethered Device. Innovations (Phila) 2016;11:174-8
Muller DWM, Farivar RS, Jansz P, et al. Transcatheter Mitral Valve Replacement for Patients With Symptomatic Mitral Regurgitation: A Global Feasibility Trial. J Am Coll Cardiol 2017;69:381-91
